“Based on the Group's strategic plan, after careful consideration, Zhou Yunshu took the initiative to propose job adjustments. After review and approval by the board of directors, he was no longer the CEO and transferred to the position of president of the company. Zhou Yunshu will continue to participate deeply in the Group's management work, and the company's executive team and strategy will maintain stability and sustainability.” At the interim results conference on the morning of August 21, Chairman Ren Jinsheng of Xiansheng Pharmaceutical expressed the above views on personnel changes in core management. On August 20, Xiansheng Pharmaceutical revealed a personnel adjustment for core management. According to the announcement, in order to further accelerate business development in China and strengthen global innovation capacity building, following Zhou Yunshu's initiative and approval by the board of directors, the founder of the company, Ren Jinsheng, has now reappointed as CEO and continues to serve as chairman and executive director; Zhou Yunshu is no longer the CEO and has been replaced as the company's president.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.